Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy
JOURNAL OF HEPATOCELLULAR CARCINOMA（2023）
关键词
unresectable hepatocellular carcinoma,alpha-fetoprotein,des-gamma-carboxyprothrombin,combination therapy,tumor response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要